NCT00314678View on ClinicalTrials.gov

Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

April 30, 2007

Conditions
Epithelial Ovarian CancerPrimary Peritoneal Cancer
Interventions
DRUG

Topotecan

DRUG

Cisplatin

DRUG

Paclitaxel

Trial Locations (1)

92868

Chao Family Comprehensive Cancer Center, Orange

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

John P. Fruehauf

OTHER